{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Nu Skin Enterprises, Inc.
Nu Skin Enterprises Hits New 52-Week Low at $5.02
Nu Skin Enterprises, Inc. has reached a new 52-week low, reflecting a significant decline over the past year. Despite this, the company maintains a market capitalization of USD 632 million, a low P/E ratio, and a strong financial position with no debt obligations and a solid return on equity.
Nu Skin Enterprises Hits New 52-Week Low at $5.15
Nu Skin Enterprises, Inc. has reached a new 52-week low, reflecting a substantial decline in its stock performance over the past year. Despite this, the company maintains a market capitalization of USD 632 million, a strong return on equity, and a low debt-to-equity ratio, indicating solid financial health.
Nu Skin Enterprises Hits New 52-Week Low at $5.52
Nu Skin Enterprises, Inc. has reached a new 52-week low, reflecting a challenging year with a significant stock price decline. Despite this, the company maintains a market capitalization of USD 639 million, strong management efficiency, low debt, and a notable dividend yield, showcasing its financial strengths amid current challenges.
Nu Skin Enterprises Hits 52-Week Low at $5.63 Amid Market Volatility
Nu Skin Enterprises, Inc. has reached a new 52-week low, reflecting a significant decline in stock performance over the past year. Despite this, the company maintains a market capitalization of USD 639 million, a low debt-to-equity ratio, and reported a net profit of USD 171.14 million in its latest results.
Nu Skin Enterprises Forms Death Cross, Signaling Bearish Trend Ahead
Nu Skin Enterprises, Inc. has recently encountered a Death Cross, indicating a potential shift in market sentiment. Technical indicators present a mixed outlook, with bearish trends noted in the MACD and Bollinger Bands. The stock has underperformed significantly, with a year-to-date decline of 20.69% and an 80.93% drop over three years.
Nu Skin Enterprises, Inc. Experiences Revision in Stock Evaluation Amid Mixed Financial Metrics
Nu Skin Enterprises, Inc. has adjusted its valuation, reporting a P/E ratio of 4 and a price-to-book value of 0.95, indicating a favorable asset valuation. Despite a strong year-to-date performance of 32.37%, the company has faced significant long-term challenges, with three- and five-year returns showing substantial declines.
Nu Skin Enterprises Hits New 52-Week High at $14.62
Nu Skin Enterprises, Inc. achieved a new 52-week high of USD 14.62 on September 23, 2025, marking a recovery for the microcap company in the FMCG sector. Despite a challenging year, its market capitalization is USD 1,036 million, with a P/E ratio of 4.00 and a return on equity of 24.02%.
Nu Skin Enterprises Hits New 52-Week High at $13.17
Nu Skin Enterprises, Inc. achieved a new 52-week high of USD 13.17 on September 22, 2025, signaling a recovery for the microcap company in the FMCG sector. With a market cap of approximately USD 1,036 million, a P/E ratio of 4.00, and a return on equity of 24.02%, the company shows strong performance metrics.
Is Nu Skin Enterprises, Inc. technically bullish or bearish?
As of August 11, 2025, Nu Skin Enterprises, Inc. shows a bullish technical trend supported by positive MACD and Bollinger Bands, despite a mildly bearish signal from the weekly Dow Theory, and has outperformed the S&P 500 with a year-to-date return of 78.81%.
Is Nu Skin Enterprises, Inc. overvalued or undervalued?
As of August 7, 2025, Nu Skin Enterprises, Inc. is considered an attractive investment due to its undervalued metrics, including a P/E ratio of 4, an EV to EBITDA ratio of 6.39, a Price to Book Value of 0.95, and a high return on equity of 23.44%, alongside strong market performance that significantly outpaces the S&P 500.
Is Nu Skin Enterprises, Inc. technically bullish or bearish?
As of June 27, 2025, Nu Skin Enterprises, Inc. shows a mildly bullish trend supported by bullish weekly MACD and moving averages, despite mixed signals from monthly Bollinger Bands and Dow Theory.
Is Nu Skin Enterprises, Inc. overvalued or undervalued?
As of May 8, 2024, Nu Skin Enterprises, Inc. is considered overvalued and risky, with a low P/E ratio of 4 and an EV to EBITDA of 6.39, indicating weak growth potential compared to peers like Olaplex, while its stock has underperformed significantly, down 38.42% over the past year.
Is Nu Skin Enterprises, Inc. technically bullish or bearish?
As of June 20, 2025, Nu Skin Enterprises, Inc. shows a mildly bearish trend based on daily moving averages and weekly Dow Theory, despite some underlying strength indicated by the weekly MACD and KST.
Who are in the management team of Nu Skin Enterprises, Inc.?
As of March 2022, the management team of Nu Skin Enterprises, Inc. includes Executive Chairman Steven Lund, CEO Ritch Wood, Lead Independent Director Daniel Campbell, and Independent Directors Andrew Lipman, Laura Nathanson, Thomas Pisano, and Zheqing Shen. They are responsible for the company's strategic direction and governance.
What does Nu Skin Enterprises, Inc. do?
Nu Skin Enterprises, Inc. is a direct selling company that develops and distributes personal care products and nutritional supplements. As of March 2025, it reported net sales of $364 million and a market cap of $698.62 million.
How big is Nu Skin Enterprises, Inc.?
As of Jun 18, Nu Skin Enterprises, Inc. has a market capitalization of 698.62 million and reported net sales of 1,679.26 million with a net loss of 38.54 million over the latest four quarters. Shareholder's funds are at 651.46 million, and total assets amount to 1,468.91 million.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
